Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease

Blood Purification

Volumn 35, Issue 1-3, 2013, Pages 196-201

  Marzocco, Stefania ^a   Dal Piaz, Fabrizio ^a   Di Micco, Lucia ^b   Torraca, Serena ^b   Sirico, Maria Luisa ^b   Tartaglia, Domenico ^b   Autore, Giuseppina ^a   Di Iorio, Biagio ^b  

^a UNIVERSITY OF SALERNO   (Italy)

^b A Landolfi Hospital   (Italy)

Author keywords

Chronic kidney disease; Indoxyl sulfate; Very low protein diet

Indexed keywords

CREATININE; INDICAN; AMINO ACID; OXOACID;

ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIET RESTRICTION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INDICAN BLOOD LEVEL; LOW PHOSPHORUS INTAKE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); AGED; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DISEASE COURSE; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL;

AGED; AMINO ACIDS; CASE-CONTROL STUDIES; CREATININE; CROSS-OVER STUDIES; DIET, PROTEIN-RESTRICTED; DISEASE PROGRESSION; FEMALE; HUMANS; INDICAN; KETO ACIDS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84874805507     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000346628     Document Type: Article

References (41)

1. Vanholder R, Baurmeister U, Brunet P, et al, European Uremic Toxin Work Group: A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008; 19: 863-870.
2. Duranton F, Cohen G, De Smet R, et al: Normal and pathological concentrations of uremic toxins. Clin J Am Soc Nephrol 2012; 23: 1258-1270.
3. Motojima M, Nishijima F, Ikoma F, et al: Role for uremic toxin in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991; 40: 461-469.
4. Evenepoel P, Meijers BK, Bammens BR, Verbeke K: Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 2009; 114:S12-S19.
5. Meijers BK, Van Kerckhoven S, Verbeke K, et al: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901.
6. Barreto FC, Barreto DV, Liabeuf S, et al, European Uremic Toxin Work Group (EUTox): Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551-1558.
7. Di Iorio B, Di Micco L, Torraca S, et al: Acute effects of very-low-protein diet on FGF23 levels: a randomized study. Clin J Am Soc Nephrol 2012; 7: 581-587.
8. Di Iorio Br, Minutolo R, De Nicola L, et al: Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int 2003; 64: 1822-1828.
9. Bellizzi V, Di Iorio BR, de Nicola l, et al: Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int 2007; 71: 245-251.
10. Zhu W, Stevens AP, Dettmer K, Gottfried E, Hoves S, Kreutz M, Holler E, Canelas AB, Kema I, Oefner PJ: Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2011; 401: 3249-3261.
11. Niwa T: Indoxyl sulphate is a nephro-vascular toxin. J Ren Nutr 2010; 20(5 suppl):2-6.
12. Muteliefu S, Shimizu H, Enomoto A, et al: Indoxyl sulphate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress. Am J Physiol Cell Physiol 2012; 303: 126-134.
13. Muteliefu G, Enomoto A, Jiang P, Takahashi M, Niwa T: Indoxyl sulphate induces oxidative stress and the expression of osteoblastspecific proteins in vascular smooth muscle cells. Nephrol Dial Transplant 2009; 24: 2051-2058.
14. Tumur Z, Niwa T: Indoxyl sulfate inhibits NO production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol 2009; 29: 551-557.
15. Mejers BKI, De loor H, Bammens B, et al: p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1932-1938.
16. Martinez AW, Recht NS, Hostetter TH, Meyer TW: Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol 2005; 16: 3430-3436.
17. Sun CY, Hsu HH, Wu MS: p-Cresol sulfate and indoxyl sulfate induce cellular inflammation gene expression in cultured proximal renal tubular cells. Nephrol Dial Trasplant 2012, E-Pub ahead of print.
18. Adijang A, Goto S, Uramoto S, et al: Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Trasplant 2008; 23: 1892-1901.
19. Mozar A, Louvet L, Godin C, et al: Indoxyl sulphate inhibits osteoclast differentiation and function. Nephrol Dial Trasplant 2012; 27: 2176-2181.
20. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T: Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Kidney Int 2003; 63: 1671-1680.
21. Gelasco AK, Raymond JR: Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Renal Physiol 2006; 290:F1551-F1558.
22. Owada S, Goto S, Bannai K, Hayashi H, Nishijima F, Niwa T: Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats. Am J Nephrol 2008; 28: 446-454.
23. Niwa T, Ise M: Indoxyl sulphate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96-104.
24. Niwa T, Ise M, Miyazaki T: Progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96-104.
25. Miyazaki T, Ise M, Hirata M, Endo K, Ito Y, Seo H, Niwa T: Indoxyl sulfate stimulates renal synthesis of transforming growth factorbeta1. and progression of renal failure. Kidney Int Suppl 1997; 63:S211-S214.
26. Miyazaki T, Ise M, Seo H, Niwa T: Indoxyl sulfate increases the gene expressions of TGFbeta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int Suppl 1997; 62:S15-S22.
27. Niwa T: Uremictoxicity of indoxyl sulfate. Nagoya J Med Sci 2010; 72: 1-11.
28. Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T: An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant 2000; 15: 1773-1781.
29. Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS: Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients -a prospective cohort study. Nephrol Dial Transplant 2012; 27: 1169-1175.
30. Niwa T: Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 1996; 16: 167-182.
31. Niwa T, Aoyama I, Takayama F, Tsukushi S, Miyazaki T, Owada A, Shiigai T: Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure. Miner Electrol Metab 1999; 25: 118-122.
32. Lida S, Kohno K, Yoshimura J, et al: Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure. Clin Exp Nephrol 2006; 10: 262-267.
33. Akizawa T, Asano Y, Morita S, et al: Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis 2009; 54: 459-467.
34. Schulman G, Agarwal R, Acharya M, et al: A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 2006; 47: 565-577.
35. Kikuchi K, Itoh Y, Tateoka R, et al: Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 2997-3002.
36. Meijers BK, De Preter V, Verbeke K, et al: p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 2010; 25: 219-224.
37. Patel KP, Luo FJ, Plummer NS, Hostetter TH, Meyer TW: The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 2012; 7: 982-988.
38. Meijers BK, Evenepoel P: The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 2011; 26: 759-761.
39. Gao X, Huang L, Grosjean F, et al: Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15. Kidney Int 2011; 79: 987-996.
40. Di Iorio B, Bellizzi V, Bellasi A, et al: Phosphate attenuates the antiproteinuric effect of very low protein diet in CKD patients. Nephrol Dial Transplant 2012, E-Pub ahead of print.
41. Fouque D, Laville M, Boissel JP: Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev 2006; 2:CD001892.